Your browser doesn't support javascript.
loading
Neuropilin1, a novel independent prognostic factor and therapeutic target in triple-negative breast cancer.
Wang, H; Zhang, Y N; Xu, D Q; Huang, J G; Lv, D; Shi, X Y; Liu, J Y; Ren, H W; Han, Z X.
Afiliación
  • Wang H; Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, China.
  • Zhang YN; Department of Oncology, Xuzhou No. 1 People's Hospital, Xuzhou, China.
  • Xu DQ; Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, China.
  • Huang JG; Department of Oncology, Peixian People's Hospital, Xuzhou, China.
  • Lv D; Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, China.
  • Shi XY; Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, China.
  • Liu JY; Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, China.
  • Ren HW; Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, China.
  • Han ZX; Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, China.
Neoplasma ; 67(6): 1335-1342, 2020 Nov.
Article en En | MEDLINE | ID: mdl-32657612

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paclitaxel / Neuropilina-1 / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Neoplasma Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Eslovaquia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paclitaxel / Neuropilina-1 / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Neoplasma Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Eslovaquia